Search Results - "Borhani, Kiandokht"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Low Dose of Lenalidomide Enhances NK Cell Activity: Possible Implication as an Adjuvant by Borhani, Kiandokht, Bamdad, Taravat, Hashempour, Tayebeh

    Published in Iranian journal of immunology (01-06-2017)
    “…Lenalidomide, a synthetic immunomodulatory drug, has a wide range of features including anti-angiogenic and anti-proliferative properties. To date, researchers…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Lenalidomide acts as an adjuvant for HCV DNA vaccine by Borhani, Kiandokht, Bamdad, Taravat, Hashempour, Tayebeh

    Published in International immunopharmacology (01-07-2017)
    “…Hepatitis C virus (HCV) is a blood-borne pathogen which has chronically infected people worldwide. Therefore, it is of utmost importance to design prophylactic…”
    Get full text
    Journal Article
  4. 4

    Comparison of the inhibitory and stimulatory effects of Core and NS3 candidate HCV vaccines on the cellular immune response by Borhani, Kiandokht, Bamdad, Taravat, Hashempour, Ava, Salek Farrokhi, Amir, Moayedi, Javad

    “…Currently, hepatitis C virus (HCV) infects nearly 3% of the global population, the majority of whom are chronically infected; however, hepatitis C vaccines are…”
    Get full text
    Journal Article
  5. 5

    A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies by Borhani, Kiandokht, Ajorloo, Mehdi, Bamdad, Taravat, Mozhgani, Sayed Hamid Reza, Ghaderi, Mostafa, Gholami, Ali Reza

    Published in Archives of Iranian medicine (01-04-2015)
    “…Rabies is a widespread neurological zoonotic disease causing significant mortality rates, especially in developing countries. Although a vaccine for rabies is…”
    Get full text
    Journal Article